Britain's Experian First-Quarter Sales Rose 11%

Credit checking business Experian said Thursday that fiscal first-quarter sales rose 11%, in line with the company's forecasts.

"While we still face challenges in some markets, we are pleased with the start we have made to the year, reflecting good performances across the group," said Chief Executive Don Robert.

For the year as a whole, he said, the company expects internal sales growth at a mid- to high single-digit rate, accelerating into the second half.

Experian spent $1.6 billion (1.16 billion euros) acquiring five businesses during the quarter to expand its geographical range. Those acquisitions include a 65% stake in Serasa, a Brazilian credit bureau in Brazil, and the acquisition of Hitwise, a market research company.

Shares in Experian slipped 1.1% to 614 pence ($12.46; 9.06 euros) on the London Stock Exchange. The company was spun out of financial-to-retail company GUS last year.


  • The Marriner S. Eccles Federal Reserve building in Washington.

    CNBC's Fed Survey shows market pros aren't very confident the Fed can end its easy money polices without a market crash, a recession or bad inflation.

  • Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Merck reported better-than-expected results, with sales of newer drugs offsetting declining sales of drugs facing generic competition.

  • Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

  • An attendee is silhouetted against a Microsoft poster at the Microsoft Developers Build Conference in San Francisco, April 2, 2014.

    An agency that enforces antimonopoly laws visited company offices in four cities, as the country more closely scrutinizes multinational companies.

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video